Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter from RG out

http://www.google.com/finance?q=var

PPS: $33.69
Market Cap: $4.19B
Shares: 124.4M
Institutional Ownership: 93%
Average Volume: 1.64M

Q1 2009 Revenue: $508M
Q1 2009 Net Income: $68M











Share
New Message
Please login to post a reply